Hydrochloric Acid

Hydrochloric Acid

SCHEMBL2259347

O=P(O)(O)C(c1ccccc1)[n+]1ccc(-c2cc[n+](-c3ccc(Oc4ccccc4)cc3)cc2)cc1.[Cl-].[Cl-]

nearest known ligand 0.43

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MMP2 P08253 3/20 0.43
▸ CA9 Q16790 3/20 0.43
▸ MMP8 P22894 2/20 0.43
▸ MMP14 P50281 2/20 0.43
▸ CA14 Q9ULX7 2/20 0.43
▸ ACP3 P15309 4/20 0.36
▸ SRD5A2 P31213 1/20 0.35
▸ ACACB O00763 2/20 0.34
▸ ACACA Q13085 2/20 0.34
▸ PGR P06401 1/20 0.33
▸ SRC P12931 1/20 0.33
▸ PTGS1 P23219 1/20 0.32
▸ CA2 P00918 3/20 0.32
▸ CA1 P00915 2/20 0.32
▸ CA12 O43570 1/20 0.32
▸ MMP9 P14780 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4334656 0.99 MMP2 (0.44) MMP2CA9MMP8MMP14CA14
Hydrochloric Acid SCHEMBL2264057 0.88 ACP3 (0.41) CA9MMP8MMP14CA14ACP3
Hydrochloric Acid SCHEMBL2259577 0.85 ACP3 (0.38) MMP8MMP14CA14ACP3SRC
Hydrochloric Acid SCHEMBL2264240 0.85 ACP3 (0.37) MMP2MMP8MMP14CA14ACP3
Hydrochloric Acid SCHEMBL2262115 0.84 MMP2 (0.41) MMP2CA9MMP8MMP14CA14
Hydrochloric Acid SCHEMBL2260405 0.82 MMP2 (0.39) MMP2CA9MMP8MMP14CA14
Hydrochloric Acid SCHEMBL2892897 0.79 ACP3 (0.39) MMP8MMP14CA14ACP3SRC
Hydrochloric Acid SCHEMBL2465409 0.78 LTA4H (0.48) CA9PGRCA2CA1
Hydrochloric Acid SCHEMBL601780 0.78 MMP2 (0.39) MMP2CA9MMP8MMP14CA14
SCHEMBL12239725 0.77 LTA4H (0.50) CA9SRD5A2PGRCA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US claimed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US claimed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP claimed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO claimed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP claimed
US-8999430-B2 Method of manufacturing display element KONICA MINOLTA HOLDINGS, INC. (JP) 2015-04-07 — — US disclosed
EP-2149816-B1 METHOD OF MANUFACTURING AN ELECTROCHROMIC DISPLAY ELEMENT KONICA MINOLTA HOLDINGS INC (JP) 2014-05-07 — — EP disclosed
US-8014056-B2 Display element and method of driving the same KONICA MINOLTA HOLDINGS, INC. (JP) 2011-09-06 — — US disclosed
US-8004742-B2 Electrochromic display device KONICA MINOLTA HOLDINGS, INC. (JP) 2011-08-23 — — US disclosed
US-20100166946-A1 METHOD OF MANUFACTURING DISPLAY ELEMENT KONICA MINOLTA HOLDINGS, INC. (JP) 2010-07-01 — — US disclosed
US-20100091353-A1 DISPLAY ELEMENT AND METHOD OF DRIVING THE SAME KONICA MINOLTA HOLDINGS, INC. (JP) 2010-04-15 — — US disclosed
EP-2149816-A1 METHOD FOR PRODUCTION OF DISPLAY ELEMENT Konica Minolta Holdings, Inc. (JP) 2010-02-03 — — EP disclosed
US-20090316249-A1 ELECTROCHROMIC DISPLAY DEVICE KONICA MINOLTA HOLDINGS, INC. (JP) 2009-12-24 — — US disclosed
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2009-10-15 — — US disclosed
US-7567371-B2 Electrochromic compounds NTERA LIMITED (IE) 2009-07-28 — — US disclosed
EP-2040115-A1 ELECTROCHROMIC DISPLAY DEVICE Konica Minolta Holdings, Inc. (JP) 2009-03-25 — — EP disclosed
US-20060110638-A1 Electrochromic compounds NTERA LIMITED (IE) 2006-05-25 — — US disclosed
EP-1594938-A1 ELECTROCHROMIC COMPOUNDS Ntera Limited (IE) 2005-11-16 — — EP disclosed
WO-2004067673-A1 ELECTROCHROMIC COMPOUNDS NTERA LIMITED (IE) 2004-08-12 — — WO disclosed
EP-1443091-A1 Electrochromic compounds Ntera Limited (IE) 2004-08-04 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090259042-A1 ELECTROCHROMIC COMPOUNDS ETV6, HCN2, EED MMP2 2943/4885CA9 1258/4885MMP8 2139/4885
US-20060110638-A1 Electrochromic compounds ETV6, HCN2, EED MMP2 2943/4885CA9 1258/4885MMP8 2139/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback